MPCC Off To Lausanne To Meet WADA

21 February 2019 04:09
The MPCC acknowledged that, starting on the 1st of March 2019, Tramadol use during races will now be forbidden by UCI rules, and blood tests will be conducted to detect this substance. As we are still waiting for similar rules regarding corticoids, the MPCC will keep doing cortisol level tests amongst member teams in 2019. On a voluntary basis, these teams commit not to line up – on any race – any rider going through corticoids treatment. The board also selected the representants that will head to Lausanne on the 12th of March to meet WADA’s officials, as we positively answered to WADA President Craig Reedie’s invite in the current context.   The President of the MPCC Roger Legeay will be accompanied by 4 members of the movement: the vice-President of the MPCC Iwan Spekenbrink, the Secretary Philippe Senmartin, the Rally-UHC Cycling team’s physician Prentice Steffen and the French federation’s Legal director Philippe Lavergne.   To conclude, as we are still waiting for the attribution of the last Tour de France wild cards, the MPCC is very satisfied with the organizers’ decision to assign the first two wild cards to MPCC members: Cofidis (France) and Wanty Groupe Gobert (Belgium). The MPCC is also delighted that the Giro d’Italia granted all of the 4 available wild cards to MPCC members: Androni – Giocatolli – Sidermec (Italy), Bardiani – CSF (Italy), Israel Cycling Academy (Israel) et Nippo – Fini Fantini – Faizane (Italy)  .read full article

Source: Kev Monks